| 246 | 3 | 15 |
| 下载次数 | 被引频次 | 阅读次数 |
目的建立奥美拉唑血药浓度测定的LC-MS/MS检测方法,并研究奥美拉唑在兔体内的药动学特征。方法 5只日本大耳白兔耳缘静脉给予奥美拉唑2 mg·kg-1,给药后10、20、30、45、60、75、90、120、150、180、240、300、360 min各采血0.5 mL,分离血浆后,加入内标奥沙西泮,以碳酸钠碱化后用乙酸乙酯萃取。流动相为乙腈-0.1%甲酸(40∶60,V/V),流速为O.3 mL·min-1。经Zorbax SB-C18柱(150 mm×2.1 mm,5μm)分离。采用电喷雾离子源,以多反应监测方式进行正离子检测,奥美拉唑m/z 346→198,奥沙西泮m/z 287→269。结果奥美拉唑血药浓度在2~1 800μg·L-1内线性关系良好,萃取回收率>65%,日内和日间RSD<10%。奥美拉唑2 mg·kg-1静脉给药后,AUC0→t(922.925±214.175)μg·h·L-1,AUC0→∞(936.61±205.951)μg·h·L-1,t1/2(1.88±0.802)h,V(6.501±4.067)L·kg-1,ρmax(1 376.94±365.795)μg·L-1。结论奥美拉唑在兔体内按二房室模型转运,代谢快,半衰期短;LC-MS/MS法操作简便、灵敏度高,适用于探针药奥美拉唑的药动学研究。
Abstract:AIM To establish a sensitive and selective LC-MS/MS method for the determination of omeprazole, and to study its pharmacokinetic characteristics in rabbits.METHODS The 0.5 mL of plasma samples were collected at 10,20,30,45,60,75,90,120,150,180,240,300 and 360 min after five Japanese rabbits were received a single intravenous administration of 2 mg·kg-1 omeprazole.Omeprazole was extracted from rabbit plasma by liquid-liquid extraction, and then analyzed on a Zorbax SB-C18(150 mm×2.1 mm,5μm) column.The mobile phase consisted of acetonitrile -0.1%formic acid(40?60,V/V)at a flow rate of 0.3 mL·min-1.A Bruker Esquire HCT mass spectrometer equipped with electrospray ionization source was used as detector and was operated in the positive ion mode.Quantification was performed using multiple reaction monitoring of the transitions m/z 346→198 and m/z 287→269 for omeprazole and the internal standard,respectively.RESULTS The linear calibration curves were obtained in the concentration range of 2-1 800μg·L-1.The lower limit of quantification was 2μg·L-1.The intra-day and inter-day relative standard deviations were less than 10%.The pharmacokinetics of omeprazole was as follows:AUC0→t(922.925±214.175)μg·h·L-1,AUC0→∞(936.61±205.95l)μg·h·L-1,t1/2(1.88±0.802) h,V(6.501±4.067) L·kg-1,andρmax(1 376.94±365.795)μg·L-1.CONCLUSION The pharmacokinetic parameters of omeprazole in rabbits are fitted to two compartment model,and omeprazoloe is eliminated fastly.The method is rapid,selective and is proved to be suitable for pharmacokinetic study for omeprazole.
[1]曾云.奥美拉唑与泮托拉唑治疗消化道溃疡出血的比较[J].贵阳医学院学报,2008,33(3):282.
[2]张向红,刘瑞雪.小剂量奥美拉唑治疗功能性消化不良的临床研究[J].中国实用内科杂志,2008,28(3):211.
[3]Kanazawa H,Okada A,Higaki M,et al.Stereospecific analysis of omeprazole in human plasma as a probe for CYP2C19 phenotype[J].J Pharm Biomed Anal,2003,30(6):1817.
[4]Skaanild MT,Friis C.Analyses of CYP2C in porcine microsomes[J]. Basic din Pharmacol Toxicol,2008,103(5):487.
[5]邓子煜,李雪宁,陈秋潮.HPLC测定奥美拉唑血药浓度[J].中国药学杂志,1996,31(10):608.
[6]邢增术,庄仁志,吴秀琼,等.奥美拉唑肠溶胶囊的生物等效性研究[J].海南医学院学报,2008,14(2):110.
[7]Jia H,Li W,Zhao K.Determination of omeprazole in rat plasma by high-performance liquid chromatography without solvent extraction[J].J Chromatogr B Analyt Technol Biomed Life Sci,2006,837(1 -2):112.
[8]Lewis DF,Dickins M,Lake BG,et al.Investigation of enzyme selectivity in the human CYP2C subfamily:homology modelling of CYP2C8,CYP2C9 and CYP2C19 from the CYP2C5 crystallographic template[J].Drug Metabol Drug Interact,2003,19(4):257.
[9]Litalien C,Theoret Y,Faure C,et al.Phatmacokinetics of proton pump inhibitors in children[J].Clin Pharmacokinet,2005,44(5):441.
[10]蔡鸿生,张先洲,李荣凌,等.奥美拉唑注射液药动学研究[J].中国医院药学杂志,1994,14(7):293.
[11]付良青,黄丰,吴德政,等.中国CYP2C19强代谢者与弱代谢者的奥美拉唑及其代谢物的药动学比较[J].中国药学杂志, 2004,39(8):614.
基本信息:
DOI:10.19577/j.cnki.issn10074406.2010.05.008
中图分类号:R96
引用信息:
[1]曹高忠,郑仰明,李军伟,等.LC-MS/MS法测定奥美拉唑在兔血浆中的浓度及其药动学特征[J].中国临床药学杂志,2010,19(05):291-295.DOI:10.19577/j.cnki.issn10074406.2010.05.008.
基金信息:
浙江省中医药科技计划(编号2009CB054); 温州市科技计划(编号Y20090174)
2010-09-25
2010-09-25